We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
246
Reduced
378
Closed
79
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Northeast Bank
NBN
$1.08B
| $2.37M | ﹤0.01% |
256,730
+1,370
| +0.5% | +$12.8K |
2013 Q2
7 quarters
|
|
|
HALL
602
DELISTED
Hallmark Financial Services, Inc.
HALL
| $2.36M | ﹤0.01% |
22,251
+2,973
| +15% | +$329K |
2013 Q2
7 quarters
|
|
|
SNBC
603
DELISTED
Sun Bancorp Inc
SNBC
| $2.32M | ﹤0.01% |
+122,870
| New | +$2.28M |
2015 Q1
0 quarters
|
|
|
COVS
604
DELISTED
Covisint Corporation
COVS
| $2.32M | ﹤0.01% |
1,140,668
+974,432
| +586% | +$2.27M |
2014 Q4
1 quarter
|
|
605
Iovance Biotherapeutics
IOVA
$6.17B
| $2.31M | ﹤0.01% |
+190,969
| New | +$2.15M |
2015 Q1
0 quarters
|
|
606
Service Corp International
SCI
$11.1B
| $2.31M | ﹤0.01% |
88,709
-1,364
| -2% | -$33.2K |
2013 Q2
7 quarters
|
|
607
Ares Capital
ARCC
$13.4B
| $2.29M | ﹤0.01% |
133,523
+5,606
| +4% | +$93.6K |
2013 Q2
7 quarters
|
|
608
Blackstone Mortgage Trust
BXMT
$1.77B
| $2.25M | ﹤0.01% |
79,481
-6,143
| -7% | -$177K |
2014 Q2
3 quarters
|
|
|
FSGI
609
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
| $2.25M | ﹤0.01% |
936,350
+248,145
| +36% | +$559K |
2014 Q2
3 quarters
|
|
610
PTC
PTC
$21B
| $2.23M | ﹤0.01% |
+61,793
| New | +$2.13M |
2015 Q1
0 quarters
|
|
611
Constellium
CSTM
$3.45B
| $2.22M | ﹤0.01% |
109,259
-8,562
| -7% | -$161K |
2014 Q4
1 quarter
|
|
612
Winnebago Industries
WGO
$678M
| $2.14M | ﹤0.01% |
+100,860
| New | +$2.17M |
2015 Q1
0 quarters
|
|
613
Greif Class B
GEF.B
$4.19B
| $2.13M | ﹤0.01% |
46,351
-3,572
| -7% | -$163K |
2013 Q2
7 quarters
|
|
614
Assurant
AIZ
$14B
| $2.12M | ﹤0.01% |
34,581
+1,492
| +5% | +$94.5K |
2013 Q2
7 quarters
|
|
615
Ameris Bancorp
ABCB
$5.35B
| $2.08M | ﹤0.01% |
78,967
-6,718
| -8% | -$170K |
2013 Q2
7 quarters
|
|
616
Genie Energy
GNE
$439M
| $2.07M | ﹤0.01% |
260,060
-55,940
| -18% | -$377K |
2014 Q2
3 quarters
|
|
|
MWW
617
DELISTED
Monster Worldwide Inc
MWW
| $2.07M | ﹤0.01% |
325,813
-25,549
| -7% | -$140K |
2014 Q4
1 quarter
|
|
618
DELISTED
Everi Holdings
EVRI
| $2.06M | ﹤0.01% |
269,710
-21,139
| -7% | -$151K |
2014 Q3
2 quarters
|
|
619
Heritage Financial
HFWA
$1.13B
| $2.01M | ﹤0.01% |
118,018
-9,705
| -8% | -$159K |
2013 Q2
7 quarters
|
|
|
TGA
620
DELISTED
Transglobe Energy Corp
TGA
| $2M | ﹤0.01% |
563,419
+97,215
| +21% | +$304K |
2014 Q3
2 quarters
|
|
621
Alphatec Holdings
ATEC
$1.62B
| $1.98M | ﹤0.01% |
113,707
-8,792
| -7% | -$147K |
2014 Q1
4 quarters
|
|
622
DELISTED
First of Long Island Corp
FLIC
| $1.96M | ﹤0.01% |
115,404
+780
| +0.7% | +$13K |
2013 Q2
7 quarters
|
|
623
Gran Tierra Energy
GTE
$386M
| $1.96M | ﹤0.01% |
71,685
+13,652
| +24% | +$370K |
2014 Q3
2 quarters
|
|
|
NXGN
624
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.96M | ﹤0.01% |
122,378
-9,550
| -7% | -$158K |
2014 Q3
2 quarters
|
|
|
TIVO
625
DELISTED
Tivo Inc
TIVO
| $1.95M | ﹤0.01% |
106,789
-8,209
| -7% | -$184K |
2013 Q2
7 quarters
|
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 246 increased, 378 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.